MX9205678A - Heteroarilaminas como nuevos inhibidores de la acetilcolinesterasa. - Google Patents
Heteroarilaminas como nuevos inhibidores de la acetilcolinesterasa.Info
- Publication number
- MX9205678A MX9205678A MX9205678A MX9205678A MX9205678A MX 9205678 A MX9205678 A MX 9205678A MX 9205678 A MX9205678 A MX 9205678A MX 9205678 A MX9205678 A MX 9205678A MX 9205678 A MX9205678 A MX 9205678A
- Authority
- MX
- Mexico
- Prior art keywords
- heteroarilamines
- acetylcholinesterase
- new inhibitors
- inhibitors
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77128391A | 1991-10-03 | 1991-10-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9205678A true MX9205678A (es) | 1993-04-01 |
Family
ID=25091318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9205678A MX9205678A (es) | 1991-10-03 | 1992-10-02 | Heteroarilaminas como nuevos inhibidores de la acetilcolinesterasa. |
Country Status (36)
| Country | Link |
|---|---|
| US (4) | US5574046A (es) |
| EP (1) | EP0606248B1 (es) |
| JP (1) | JP2546785B2 (es) |
| KR (1) | KR0170458B1 (es) |
| CN (1) | CN1035615C (es) |
| AP (1) | AP314A (es) |
| AT (1) | ATE235490T1 (es) |
| AU (1) | AU667053B2 (es) |
| BG (1) | BG61727B1 (es) |
| BR (1) | BR9206577A (es) |
| CA (1) | CA2119647C (es) |
| CZ (1) | CZ290807B6 (es) |
| DE (2) | DE69232976T2 (es) |
| DK (1) | DK0606248T3 (es) |
| EG (1) | EG21481A (es) |
| ES (1) | ES2193137T3 (es) |
| FI (1) | FI116939B (es) |
| HU (1) | HU225049B1 (es) |
| IL (1) | IL103274A (es) |
| IS (1) | IS1745B (es) |
| MA (1) | MA22672A1 (es) |
| MX (1) | MX9205678A (es) |
| NO (1) | NO308533B1 (es) |
| NZ (1) | NZ244601A (es) |
| OA (1) | OA09895A (es) |
| PH (1) | PH31290A (es) |
| PL (3) | PL171984B1 (es) |
| PT (1) | PT100917B (es) |
| RO (1) | RO112868B1 (es) |
| RU (1) | RU2100357C1 (es) |
| SG (1) | SG52618A1 (es) |
| TW (1) | TW263504B (es) |
| UA (1) | UA41290C2 (es) |
| UY (1) | UY23484A1 (es) |
| WO (1) | WO1993007140A1 (es) |
| ZA (1) | ZA927589B (es) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5620973A (en) * | 1993-11-30 | 1997-04-15 | Takeda Chemical Industries, Ltd. | Tetracyclic condensed heterocyclic compounds and their use |
| EP0976404A3 (en) * | 1998-07-30 | 2001-06-27 | Pfizer Products Inc. | A pharmaceutical composition for the prevention and treatment of diseases of cognitive dysfunction in a mammal |
| US6218383B1 (en) | 1998-08-07 | 2001-04-17 | Targacept, Inc. | Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
| EP1891954A3 (en) | 1998-09-30 | 2009-01-14 | Takeda Pharmaceutical Company Limited | Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder |
| CN1317276C (zh) * | 2000-09-29 | 2007-05-23 | 中国科学院上海药物研究所 | 一类吲哚基哌啶类化合物及其制备方法和用途 |
| PL361887A1 (en) * | 2000-10-20 | 2004-10-04 | Biovitrum Ab | 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| JP2006505571A (ja) * | 2002-10-15 | 2006-02-16 | リゲル ファーマシューテイカルズ、インコーポレイテッド | 置換されたインドール及びｈｃｖ阻害剤としてのその使用 |
| US20060014801A1 (en) * | 2002-11-22 | 2006-01-19 | The Johns Hopkins University | Prevention and treatment of cognitive impairment using (R)-(-)-5-methyl-1-nicotynoyl-2-pyrazoline (MNP) and analogs |
| WO2005112908A1 (en) * | 2004-05-14 | 2005-12-01 | The Johns Hopkins University | Method for improving cognitive function |
| EP1600447A1 (en) * | 2004-05-28 | 2005-11-30 | Neuropharma S.A.U. | Butyrylcholinesterase selective inhibitors |
| PT1753764E (pt) | 2004-06-09 | 2009-01-28 | Glaxo Group Ltd | Derivados de pirrolopiridina |
| CN101087618A (zh) * | 2004-12-23 | 2007-12-12 | 航行药物公司 | 醋酸亮丙瑞林和乙酰胆碱酯酶抑制剂或nmda受体抑制剂在阿尔茨海默氏病治疗中的应用 |
| CN1808106B (zh) * | 2005-01-21 | 2010-11-24 | 中国科学院上海药物研究所 | 一种用核磁共振筛选乙酰胆碱酯酶抑制剂的方法 |
| JP5833922B2 (ja) | 2008-08-12 | 2015-12-16 | ジンファンデル ファーマシューティカルズ インコーポレイテッド | 疾患危険因子を同定する方法 |
| US8846315B2 (en) | 2008-08-12 | 2014-09-30 | Zinfandel Pharmaceuticals, Inc. | Disease risk factors and methods of use |
| CN101503414B (zh) * | 2009-03-04 | 2013-10-30 | 沈阳药科大学 | 噻唑并[3,2-b]-1,2,4-三嗪衍生物及其应用 |
| NO2482815T3 (es) | 2009-10-02 | 2018-09-29 | ||
| CN102905532A (zh) | 2010-02-09 | 2013-01-30 | 约翰斯.霍普金斯大学 | 用于改善认知功能的方法和组合物 |
| EP2665479B1 (en) | 2011-01-10 | 2019-06-26 | Zinfandel Pharmaceuticals, Inc. | Methods and drug products for treating alzheimer's disease |
| CA2891122C (en) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| AU2014211489A1 (en) | 2013-01-29 | 2015-08-13 | Avexxin As | Antiinflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds |
| WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| WO2014144801A1 (en) | 2013-03-15 | 2014-09-18 | Agenebio Inc. | Methods and compositions for improving cognitive function |
| CN103333163A (zh) * | 2013-07-09 | 2013-10-02 | 广州中医药大学 | 一种苯并呋喃类衍生物及其制备方法和应用 |
| GB201413695D0 (en) | 2014-08-01 | 2014-09-17 | Avexxin As | Compound |
| EA034167B8 (ru) | 2015-05-22 | 2021-04-27 | Эйджинбайо, Инк. | Фармацевтические композиции леветирацетама пролонгированного высвобождения |
| GB201604318D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
| CN107141266B (zh) * | 2017-06-28 | 2019-04-09 | 佳木斯大学附属第一医院 | 一种用于治疗阿尔茨海默病的杂环化合物及其制备方法 |
| CN115466211B (zh) * | 2022-06-09 | 2024-02-23 | 中国人民解放军空军军医大学 | 一种n-苯基喹啉-4-胺类化合物及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1068259B (es) * | 1954-04-28 | 1959-11-05 | ||
| FR2334358A1 (fr) * | 1975-12-12 | 1977-07-08 | Sogeras | Nouveaux medicaments derives de l'indole |
| US4122265A (en) * | 1976-05-21 | 1978-10-24 | Hoffmann-La Roche Inc. | Derivatives of 3-phenylisoindole-1-carboxylic acid |
| ZA815541B (en) * | 1980-08-12 | 1983-03-30 | Glaxo Group Ltd | Heterocyclic compounds |
| GB8615562D0 (en) * | 1986-06-25 | 1986-07-30 | Maggioni Farma | Aminoalcohols |
| KR910006138B1 (ko) * | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | 환상아민 유도체 |
| FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| IT1226100B (it) * | 1988-07-07 | 1990-12-10 | Dompe Farmaceutici Spa | Derivati benzimidazolici farmacologicamente attivi. |
| FR2640266B2 (fr) * | 1988-07-12 | 1992-07-10 | Synthelabo | Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique |
| US4908372A (en) * | 1988-10-13 | 1990-03-13 | Merrell Dow Pharmaceuticals Inc. | Antihistaminic piperidinyl benzimidazoles |
| JP2969359B2 (ja) * | 1989-01-13 | 1999-11-02 | 武田薬品工業株式会社 | 環状アミン化合物 |
| US5064840A (en) * | 1989-08-03 | 1991-11-12 | Merrell Dow Pharmaceuticals | Anti-psychotic piperidylbenzimidazole compounds |
| TW197442B (es) * | 1990-02-08 | 1993-01-01 | Pfizer | |
| US5116846A (en) * | 1990-03-28 | 1992-05-26 | Du Pont Merck Pharmaceutical Company | N-aralkyl piperidine derivatives as psychotropic drugs |
| TW197435B (es) * | 1990-11-22 | 1993-01-01 | Takeda Pharm Industry Co Ltd | |
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| CA2129995C (en) * | 1992-02-13 | 2000-04-11 | Albert A. Carr | Piperidinyl thiacyclic derivatives |
| TW226019B (es) * | 1992-03-23 | 1994-07-01 | Sankyo Co |
-
1992
- 1992-08-29 TW TW081106843A patent/TW263504B/zh active
- 1992-08-31 DE DE69232976T patent/DE69232976T2/de not_active Expired - Fee Related
- 1992-08-31 EP EP92918761A patent/EP0606248B1/en not_active Expired - Lifetime
- 1992-08-31 CZ CZ1994785A patent/CZ290807B6/cs not_active IP Right Cessation
- 1992-08-31 DE DE9290112U patent/DE9290112U1/de not_active Expired - Lifetime
- 1992-08-31 BR BR9206577A patent/BR9206577A/pt not_active Application Discontinuation
- 1992-08-31 RO RO94-00533A patent/RO112868B1/ro unknown
- 1992-08-31 AU AU25196/92A patent/AU667053B2/en not_active Ceased
- 1992-08-31 PL PL92312751A patent/PL171984B1/pl not_active IP Right Cessation
- 1992-08-31 AT AT92918761T patent/ATE235490T1/de not_active IP Right Cessation
- 1992-08-31 JP JP5506442A patent/JP2546785B2/ja not_active Expired - Fee Related
- 1992-08-31 KR KR1019940701066A patent/KR0170458B1/ko not_active IP Right Cessation
- 1992-08-31 PL PL92303096A patent/PL171669B1/pl not_active IP Right Cessation
- 1992-08-31 ES ES92918761T patent/ES2193137T3/es not_active Expired - Lifetime
- 1992-08-31 UA UA94005424A patent/UA41290C2/uk unknown
- 1992-08-31 DK DK92918761T patent/DK0606248T3/da active
- 1992-08-31 WO PCT/US1992/007230 patent/WO1993007140A1/en active IP Right Grant
- 1992-08-31 HU HU9400952A patent/HU225049B1/hu unknown
- 1992-08-31 RU RU9494019972A patent/RU2100357C1/ru not_active IP Right Cessation
- 1992-08-31 SG SG1996006904A patent/SG52618A1/en unknown
- 1992-08-31 CA CA002119647A patent/CA2119647C/en not_active Expired - Fee Related
- 1992-08-31 US US08/211,044 patent/US5574046A/en not_active Expired - Lifetime
- 1992-08-31 PL PL92312752A patent/PL171693B1/pl not_active IP Right Cessation
- 1992-09-07 AP APAP/P/1992/000421A patent/AP314A/en active
- 1992-09-15 PH PH44935A patent/PH31290A/en unknown
- 1992-09-24 IL IL10327492A patent/IL103274A/en not_active IP Right Cessation
- 1992-09-25 IS IS3919A patent/IS1745B/is unknown
- 1992-09-30 EG EG58192A patent/EG21481A/xx active
- 1992-09-30 CN CN92112079A patent/CN1035615C/zh not_active Expired - Fee Related
- 1992-10-01 PT PT100917A patent/PT100917B/pt not_active IP Right Cessation
- 1992-10-02 UY UY23484A patent/UY23484A1/es not_active IP Right Cessation
- 1992-10-02 MX MX9205678A patent/MX9205678A/es unknown
- 1992-10-02 MA MA22956A patent/MA22672A1/fr unknown
- 1992-10-02 NZ NZ244601A patent/NZ244601A/en not_active IP Right Cessation
- 1992-10-02 ZA ZA927589A patent/ZA927589B/xx unknown
-
1994
- 1994-03-18 OA OA60484A patent/OA09895A/en unknown
- 1994-03-30 NO NO941179A patent/NO308533B1/no unknown
- 1994-03-31 FI FI941518A patent/FI116939B/fi active IP Right Grant
- 1994-03-31 BG BG98689A patent/BG61727B1/bg unknown
-
1997
- 1997-10-24 US US08/957,639 patent/US6124321A/en not_active Expired - Fee Related
-
1999
- 1999-11-11 US US09/438,712 patent/US6303633B1/en not_active Expired - Fee Related
-
2001
- 2001-08-23 US US09/935,903 patent/US20020049210A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9205678A (es) | Heteroarilaminas como nuevos inhibidores de la acetilcolinesterasa. | |
| MX9204425A (es) | Derivados de quinazolina como inhibidores de la acetilcolinesterasa. | |
| DE3864608D1 (de) | Hmg-coa-reduktasehemmer. | |
| DE3886433D1 (de) | Desodoriervorrichtung. | |
| DE59201977D1 (de) | Einmesser-Reibahle. | |
| DK317287D0 (da) | Reduktase-inhibitorer | |
| FR2694497B1 (fr) | Desodorisant de table. | |
| MX9204190A (es) | Derivdos de 2-(4-hidroxipiperidino)-1-alcanol como agentes antiisquemicos. | |
| FI924012A0 (fi) | Korvoeverdragsmaskin med foerbaettrat spiralformningsmunstycke. | |
| DE69017543D1 (de) | Acetylcholinesterase-Inhibitoren. | |
| NO884959D0 (no) | Resorberbar protese. | |
| MX9205003A (es) | Derivados novedosos de benzopirano. | |
| FI931747A0 (fi) | Reflexkropp, isynnerhet foer vaegmarkeringar | |
| MX9204370A (es) | Derivados de pirazol. | |
| MX9201395A (es) | Construccion de bloque de dintel. | |
| MX9201931A (es) | Nuevos derivados de tiazol. | |
| MX9200872A (es) | Composicion de bis-bibenzimidazol. | |
| MX9205973A (es) | Derivados de benzo-isoquinolinas. | |
| FI913285A (fi) | Svavelsubstituerade mevinsyraderivat. | |
| MX9203486A (es) | (quinolin-2-imetoxi)indol como inhibidores de la biosintesis de leucotrienos). | |
| NO903429D0 (no) | Konstruksjon for beskyttelse av broennhode. | |
| MX9101669A (es) | Benzoquinonaiminas,como inhibidores de la polimerizacion de compuestos vinilaromaticos | |
| FI935130A (fi) | Raelsbund vagn med skjuttak, saerskilt foer biltransport | |
| FI880601A0 (fi) | Oglaserad keramisk kropp i form av en platta. | |
| MX9202691A (es) | Produccion de sosa comercial. |